CADTH Drug Portfolio Information Session

This annual session is an opportunity for all interested stakeholders to get the latest information about priority initiatives and process changes from the CADTH pharmaceutical reviews portfolio. Updates on other relevant CADTH initiatives will also be provided. As well, the session includes an open forum, where attendees can direct questions to CADTH President and CEO Suzanne McGurn and other senior staff at CADTH.

Questions may be sent by email to [email protected].